Description and Brand Names
Información sobre medicamentos proporcionada por: IBM Micromedex
Fludarabine belongs to the group of medicines called antimetabolites. It is used to treat a type of cancer of the white blood cells called B-cell chronic lymphocytic leukemia (CLL). This medicine is used in patients with CLL who have already been treated with an alkylating agent (eg, bendamustine) that did not work well.
Fludarabine interferes with the growth of cancer cells, which are eventually destroyed. Since the growth of normal cells may also be affected by the medicine, other effects may also occur. Some of these may be serious and must be reported to your doctor. Other effects may not be serious but may cause concern. Some effects may occur after treatment with fludarabine has been stopped.
Before you begin treatment with fludarabine, you and your doctor should talk about the good this medicine will do as well as the risks of using it.
This medicine was available only with your doctor's prescription. Oral fludarabine was withdrawn from the US market in September 2011.